These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 27440118)
1. The Role of Optical Coherence Tomography Angiography in the Diagnosis and Management of Acute Vogt-Koyanagi-Harada Disease. Aggarwal K; Agarwal A; Mahajan S; Invernizzi A; Mandadi SKR; Singh R; Bansal R; Dogra MR; Gupta V; Ocul Immunol Inflamm; 2018; 26(1):142-153. PubMed ID: 27440118 [TBL] [Abstract][Full Text] [Related]
2. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment. Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987 [TBL] [Abstract][Full Text] [Related]
3. Distinguishing features of acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy on optical coherence tomography angiography and en face optical coherence tomography imaging. Aggarwal K; Agarwal A; Deokar A; Mahajan S; Singh R; Bansal R; Sharma A; Dogra MR; Gupta V; J Ophthalmic Inflamm Infect; 2017 Dec; 7(1):3. PubMed ID: 28091938 [TBL] [Abstract][Full Text] [Related]
4. The Role of Widefield Optical Coherence Tomography Angiography in the Diagnosis and Management of Acute Vogt-Koyanagi-Harada Disease. Ding X; Shu Q; Bai X; Chang Q; Xu G; Chen L Ocul Immunol Inflamm; 2024 May; 32(4):391-401. PubMed ID: 36856749 [TBL] [Abstract][Full Text] [Related]
5. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease. Abouammoh MA; Gupta V; Hemachandran S; Herbort CP; Abu El-Asrar AM Acta Ophthalmol; 2016 Sep; 94(6):573-8. PubMed ID: 26823203 [TBL] [Abstract][Full Text] [Related]
6. Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy. Takemoto Y; Namba K; Mizuuchi K; Iwata D; Uno T; Ohno S; Hirooka K; Hashimoto Y; Saito W; Sugiyama K; Ishida S Acta Ophthalmol; 2016 Nov; 94(7):e629-e636. PubMed ID: 27079805 [TBL] [Abstract][Full Text] [Related]
7. Widefield Swept-Source OCTA in Vogt-Koyanagi-Harada Disease. Vingopoulos F; Cui Y; Katz R; Le R; Zhu Y; Wang JC; Lu Y; Sobrin L; Miller JB Ophthalmic Surg Lasers Imaging Retina; 2020 Jul; 51(7):407-412. PubMed ID: 32706899 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy. Shin WB; Kim MK; Lee CS; Lee SC; Kim H Korean J Ophthalmol; 2015 Dec; 29(6):389-95. PubMed ID: 26635455 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of angiography in Vogt-Koyanagi-Harada disease. Chee SP; Jap A; Cheung CM Am J Ophthalmol; 2010 Dec; 150(6):888-93. PubMed ID: 20933219 [TBL] [Abstract][Full Text] [Related]
10. Choroidal folds in Vogt-Koyanagi-Harada disease. Wu W; Wen F; Huang S; Luo G; Wu D Am J Ophthalmol; 2007 May; 143(5):900-901. PubMed ID: 17452188 [TBL] [Abstract][Full Text] [Related]
11. Retinal fluorescein and indocyanine green angiography and optical coherence tomography in successive stages of Vogt-Koyanagi-Harada disease. Fardeau C; Tran TH; Gharbi B; Cassoux N; Bodaghi B; LeHoang P Int Ophthalmol; 2007; 27(2-3):163-72. PubMed ID: 17273903 [TBL] [Abstract][Full Text] [Related]
13. The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease. Jap A; Chee SP Br J Ophthalmol; 2017 Feb; 101(2):186-189. PubMed ID: 27048179 [TBL] [Abstract][Full Text] [Related]
14. Need for Quantitative Measurement Methods for Posterior Uveitis: Comparison of Dual FA/ICGA Angiography, EDI-OCT Choroidal Thickness and SUN Vitreous Haze Evaluation in Stromal Choroiditis. Fabro F; Herbort CP Klin Monbl Augenheilkd; 2018 Apr; 235(4):424-435. PubMed ID: 29669371 [TBL] [Abstract][Full Text] [Related]
15. Full-field electroretinogram behavior in Vogt-Koyanagi-Harada disease: a 24-month longitudinal study in patients from acute onset evaluated with multimodal analysis. Sakata VM; Lavezzo MM; da Silva FT; Rodriguez EEC; Morita C; Abdallah SF; Oyamada MK; Hirata CE; Yamamoto JH Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2285-2295. PubMed ID: 31440820 [TBL] [Abstract][Full Text] [Related]
16. Contribution of dual fluorescein and indocyanine green angiography to the appraisal of posterior involvement in birdshot retinochoroiditis and Vogt-Koyanagi-Harada disease. Balci O; Jeannin B; Herbort CP Int Ophthalmol; 2018 Apr; 38(2):527-539. PubMed ID: 28299496 [TBL] [Abstract][Full Text] [Related]
17. Multimodal Imaging of Annular Choroidal Detachment in a Patient with Vogt-Koyanagi-Harada Disease. Kwak JH; Baek J; Ra H Ocul Immunol Inflamm; 2021 Jul; 29(5):911-914. PubMed ID: 31951785 [No Abstract] [Full Text] [Related]
18. Type 1 Choroidal Neovascularization Lesion Size: Indocyanine Green Angiography Versus Optical Coherence Tomography Angiography. Costanzo E; Miere A; Querques G; Capuano V; Jung C; Souied EH Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT307-13. PubMed ID: 27409487 [TBL] [Abstract][Full Text] [Related]
19. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Bouchenaki N; Herbort CP Ophthalmology; 2001 Jan; 108(1):54-64. PubMed ID: 11150265 [TBL] [Abstract][Full Text] [Related]
20. Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study. da Silva FT; Hirata CE; Sakata VM; Olivalves E; Preti R; Pimentel SL; Gomes A; Takahashi WY; Costa RA; Yamamoto JH BMC Ophthalmol; 2012 Aug; 12():40. PubMed ID: 22889440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]